Could a simple dye optimization save money and improve cancer surgery?

NCT ID NCT07380698

Recruiting now Knowledge-focused Sponsor: Cukurova University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how the dose and storage conditions of a dye called indocyanine green (ICG) affect its ability to find sentinel lymph nodes during surgery for cervical, endometrial, and vulvar cancers. Researchers will enroll 30 patients to see which approach works best and saves money. The goal is to make sentinel lymph node mapping more effective and affordable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: indocyanine green (ICG)
What this could lead to: If successful, this could lead to safer, more effective, and cheaper sentinel lymph node mapping for gynecological cancers.
What could go wrong: This is a small, early-phase study with only 30 participants, so results may not apply broadly. The main focus is on cost and detection rates, not a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer endometrial cancer endometrium neoplasm Uterine Cervical Neoplasms vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER ENDOMETRIAL CANCER INDOCYANINE GREEN (ICG) VULVAR CANCERS

Contacts and locations

Locations

Cukurova University
RECRUITING

Adana, 01000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.